Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Cardiotoxicity Among Lymphoma Patients Undergoing Chemotherapy: 5 Years Follow up

Farjah Hassan Al Gahtani, Ghada Alsadhan, Leena Almazyad, Mona Alomairini, Nora Aldahash, Munira Alsadhan, Rand Alrefaei, Sarah Alquwayz, Ghazi S Alotaibi, Aamer Aleem, Sarah Sewaralthahab

Blood (2024) 144 (Supplement 1): 6485.

https://doi.org/10.1182/blood-2024-206300

Published: 2024

Journal Articles

Quality of Life in Saudi Arabian Sickle Cell Patients: Expanded Follow-up Survey

Sarah Sewaralthahab, Hafiz Mosa Malhan, Abdullah Hasan Al Zayed, Ibrahim Alrumaih, Ghazi S Alotaibi, Fatimah Alshalati, Farjah Algahtani, Aamer Aleem, Khalid Alsaleh

Blood (2024) 144 (Supplement 1): 7533.

https://doi.org/10.1182/blood-2024-209063

Published: 2024

Journal Articles

Thrombotic Complications in Inflammatory Bowel Disease: The Role of Coagulation Markers and Family History

Farjah Algahtani, Mansour Altuwaijri, Maria Saeed, Abdulrahman Aljebreen, Aamer Aleem, Sarah Sewaralthahab, Ghazi S Alotaibi, Abdulelah Alanazi, Nahla Azzam, Majid Almadi, Othman AlHarbi

Blood (2023) 142 (Supplement 1): 5554.

https://doi.org/10.1182/blood-2023-189569

Published: 2023

Journal Articles

Risk Factors for Thrombosis in Essential Thrombocythemia: A Clinico-Pathological Study of 138 Patents in a Middle Eastern Population

Aamer Aleem, Abdullah Alqahtani, Leena Alshaman, Nawaf Aldawsari, Farjah Algahtani, Ahmed Jamal, Zafar Iqbal, Musa Alzahrani, Khalid AlSaleh, Sarah Sewaralthahab, Fatimah Alshalati, Naif Saud Albudayri, Ghazi S Alotaibi

Blood (2023) 142 (Supplement 1): 6435.

https://doi.org/10.1182/blood-2023-190259

Published: 2023

Journal Articles

Assessing Aspects of Quality of Life Among Patients with Sickle Cell Disease in Saudi Arabia

Khalid AlSaleh, Sarah Sewaralthahab, Aamer Aleem, Ghazi S Alotaibi, Farjah Algahtani, Ibrahim Alrumaih, Fatimah Alshalati, Osama Zamel, Abdullah Hasan Al Zayed, Hafiz Mosa Malhan

Blood (2023) 142 (Supplement 1): 5311.

https://doi.org/10.1182/blood-2023-182264

Published: 2023

Journal Articles

Discovery of Mutated MUC3A Gene As a Novel Transcription Factor Exclusively Associated with Accelerated Phase Chronic Myeloid Leukemia: Hunt for Common Biomarker of Fatal CML Progression

Sameen Shahid, Muhammad Sabar, Abid Jamil, Muhammad Abbas Khokar, Muhammad Absar, Mudassar Iqbal, Masood A. Shammas, Giuseppe Saglio, Sulman Basit, Sibtain Afzal, Khushnooda Ramzan, Aamer Aleem, Amer Mahmood, Nawaf Alanzazi, Muhammad Javed Asif, Mahmood Rasool, Ahmad Khalid, Zafar Iqbal

Blood (2023) 142 (Supplement 1): 7429.

https://doi.org/10.1182/blood-2023-185547

Published: 2023

Journal Articles

Clinical and Pathologic Characteristics of Essential Thrombocythemia (ET) Patients Harboring Calreticulin (CALR) Mutations

Aamer Aleem, Abdullah Algahtani, Leena Alshaman, Nawaf Aldawsari, Farjah Alqahtani, Musa Alzahrani, Ghazi Alotaibi, Saeed Alturki, Zafar Iqbal

Blood (2022) 140 (Supplement 1): 12282–12283.

https://doi.org/10.1182/blood-2022-169941

Published: 2022

Journal Articles

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Aamer Aleem, Farjah Alqahtani, Ahmed Jamal, Nora A. Alkhudair, Mashail Alghafis, Hajar Wan Zuki Siti, Bader Alahmari, Hend Salama, Giamal Edin Gmati, Mohsen Alzahrani, Ayman Alhejazi, Naila A. Shaheen, Abdullah M Alrajhi, Mansour Alfayez, Zafar Iqbal, Ahmed Alaskar

Blood (2022) 140 (Supplement 1): 12220–12221.

https://doi.org/10.1182/blood-2022-168926

Published: 2022

Journal Articles

Clinicopathological Description from the Largest Series of Patients with the Novel Pro106Leu MPL gene Mutation Associated with Hereditary Thrombocythemia

Musa Alzahrani, MBBS, MHSc, Areej Al Mugairi, Saeed Al Turki, Waleed Al Rajban, Fatimah Alshalati, Khadega A. Abuelgasim, Bader Alahmari, Thamer Al Bogami, Osama Ali, MD, Fahad Almodaihsh, Maram Alotaibi, Aamer Aleem, MBBS, FRCP, FRCPath, Ahmed Alaskar, MD FRCPC

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-136077

Published: 2020

Journal Articles

Next-Generation Sequencing Identifies a Previously Uncharacterized Gene ANKRD36 As a Common Biomarker for Blast Crisis Chronic Myeloid Leukemia: Molecular and Protein Bio-Modeling Studies

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-143068

Published: 2020

Journal Articles

Impact of Red Blood Cell Transfusions on Height and Growth of Adolescents with Sickle Cell Disease & Short Stature

Aamer Aleem, MBBS, FRCP, FRCPath, Abdulrahman Alsultan, Ammara Afzal, MD, Sami Alotaibi, MD, Zafar Iqbal, BSc, MSc, PhD, Khalid AlSaleh, MBBS, FRCPC, MRCP

Blood (2018) 132 (Supplement 1): 4935.

https://doi.org/10.1182/blood-2018-99-111591

Published: 2018

Journal Articles

Brief Research Report: Novel Compound BCR-ABL Mutations in Late Chronic Phase Imatinib Sensitive CML Patients Are Associated with Progression to Advance Disease Phase

Zafar Iqbal, MPhil PhDPost-doc., Afia Muhammad Akram, Tanveer Akhtar, PhD, Aamer Aleem, MBBS FRCP, Muhammad Farooq Sabar, PhD, Zeba Aziz, MD MBBS, Nadia Sajid, Mahmood Rasool, PhD, Muhammad Asif, Mehmood Husssain Qazi, PhD, Saleh Oraibi, PhD, Ammara T Gill, MBBS ABIM, Khalid Al Jamaan, MDFRCPC, Mudassar Iqbal, MDMS, Ahmad Mukhtar Khalid

Blood (2016) 128 (22): 3089.

https://doi.org/10.1182/blood.V128.22.3089.3089

Published: 2016

Journal Articles

High Frequencies of Compound BCR-ABL Mutations and Their Association with Imatinib Resistant, Disease Progression and Late Chronic Phase Disease in Pakistani Chronic Myeloid Leukemia Patients Necessitate the Inclusion of Molecular Testing in Routine Clinical Settings

Zafar Iqbal, PhD, Afia Muhammad Akram, Tanveer Akhtar, PhD, Muhammad Khalid, MPhil PhD, Zeba Aziz, MD MBBS, Aamer Aleem, MBBS FRCP, Ammara T Gill, MBBS ABIM, Ahmad M Khalid, PhD, Abdullah Alanazi, MBBS, Ijaz H Shah, MD, Muhammad Khalid, MBBS, MPhil, Muhammad Farooq Sabar, PhD, Mudassar Iqbal

Blood (2015) 126 (23): 5167.

https://doi.org/10.1182/blood.V126.23.5167.5167

Published: 2015

Journal Articles

Favorable and Sustained Response of Primary Autoimmune Hemolytic Anemia to Rituximab

Abdul Kareem M Al-Momen, MD, FRCPC, Aamer Aleem, MD, Farjah Al Gahtani, MD, Rana Hasanato, MBBS, MD, Farhan Ali Anjum, MBBS, Sri-Halima Blecana, MBBS, Khalid AlSaleh, MBBS, FRCPC, MRCP

Blood (2012) 120 (21): 5160.

https://doi.org/10.1182/blood.V120.21.5160.5160

Published: 2012

Journal Articles

Presence of Prior-to-Treatment BCR-ABL Mutations In CD34+CD38- Stem Cells of Newly Diagnosed Chronic Phase CML Patients and Their Correlation with Imatinib Resistance: Implications of Cancer Pharmacogenomics and Pre-Therapeutic Genetic Testing In Personalized Treatment of BCR-ABL+ Leukemia

Zafar Iqbal, BSc, MSc, MPhil, PhD, Mudassar Iqbal, MD, Tanveer Akhtar, MSc, PhD, Mubashar Iqbal Naqvi, BS(CS), Ammara H Tahir, MBBS, Tariq Jameel Gill, MBBS, Muhammad Naeem Abbas, MLT, Abid Jamil, MBBS, PhD, Abid Sohail Taj, MBBS, PhD, Dr Abd-Al-Qayyum, MD, Najeeb ur-Rehman, BS, (Engg), Muhammad Ferhan, MSc, MPhil, Ijaz Hussain Shah, MBBS, FCPS, Muhammad Khalid, MBBS, FCPS, Weng Xian Qin, BSc(MLT), MS, Ahmad Mukhtar Khalid, MSc, PhD, Mahwish Khan, Aamer Aleem, MD, Shahid Mahmood Baig, MPhil, PhD

Blood (2010) 116 (21): 2278.

https://doi.org/10.1182/blood.V116.21.2278.2278

Published: 2010

Journal Articles

Fetal Hemoglobin In Sickle Cell Anemia: Molecular Characterization of Saudi Patients From the Southwestern Province.

Abdulrahman Alsultan, MD, Nadia Solovieff, Aamer Aleem, MBBS, Farjah H. AlGahtani, MBBS, Ali Al-Shehri, MBBS, Mohamed Elfaki Osman, MBBS, Kadijah Kurban, MBBS, Hasan Bahakim, MD, Abdul Kareem Al-Momen, MBBS, FRCPC, David H.K. Chui, MD, Martin H. Steinberg, MD

Blood (2010) 116 (21): 1621.

https://doi.org/10.1182/blood.V116.21.1621.1621

Published: 2010

Journal Articles

Evaluation of Possible Risk Factors for Avascular Necrosis of the Femoral head in patients with Sickle Cell Disease

Abdul Kareem Al-Momen, MD, FRCPC, Tarek Owaidah, MD, FRCPA, Nizar Naqshabandi, MBBS, FRCPC, Rana Hasanato, MBBS, MD, Sri-Halima Cana, MBBS, Abdul Qayum, MBBS, MD, Marwan Zamzami, MBBS, FRCSC, Aamer Aleem, MD

Blood (2010) 116 (21): 4819.

https://doi.org/10.1182/blood.V116.21.4819.4819

Published: 2010

NARROW

Cardiotoxicity Among Lymphoma Patients Undergoing Chemotherapy: 5 Years Follow up

Quality of Life in Saudi Arabian Sickle Cell Patients: Expanded Follow-up Survey

Thrombotic Complications in Inflammatory Bowel Disease: The Role of Coagulation Markers and Family History

Risk Factors for Thrombosis in Essential Thrombocythemia: A Clinico-Pathological Study of 138 Patents in a Middle Eastern Population

Assessing Aspects of Quality of Life Among Patients with Sickle Cell Disease in Saudi Arabia

Discovery of Mutated MUC3A Gene As a Novel Transcription Factor Exclusively Associated with Accelerated Phase Chronic Myeloid Leukemia: Hunt for Common Biomarker of Fatal CML Progression

Clinical and Pathologic Characteristics of Essential Thrombocythemia (ET) Patients Harboring Calreticulin (CALR) Mutations

Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment-Free Remission in Chronic-Phase Chronic Myeloid Leukemia: An Observational Retrospective Multi-Center Study

Clinicopathological Description from the Largest Series of Patients with the Novel Pro106Leu MPL gene Mutation Associated with Hereditary Thrombocythemia

Next-Generation Sequencing Identifies a Previously Uncharacterized Gene ANKRD36 As a Common Biomarker for Blast Crisis Chronic Myeloid Leukemia: Molecular and Protein Bio-Modeling Studies

Impact of Red Blood Cell Transfusions on Height and Growth of Adolescents with Sickle Cell Disease & Short Stature

Brief Research Report: Novel Compound BCR-ABL Mutations in Late Chronic Phase Imatinib Sensitive CML Patients Are Associated with Progression to Advance Disease Phase

High Frequencies of Compound BCR-ABL Mutations and Their Association with Imatinib Resistant, Disease Progression and Late Chronic Phase Disease in Pakistani Chronic Myeloid Leukemia Patients Necessitate the Inclusion of Molecular Testing in Routine Clinical Settings

Favorable and Sustained Response of Primary Autoimmune Hemolytic Anemia to Rituximab

Presence of Prior-to-Treatment BCR-ABL Mutations In CD34+CD38- Stem Cells of Newly Diagnosed Chronic Phase CML Patients and Their Correlation with Imatinib Resistance: Implications of Cancer Pharmacogenomics and Pre-Therapeutic Genetic Testing In Personalized Treatment of BCR-ABL+ Leukemia

Fetal Hemoglobin In Sickle Cell Anemia: Molecular Characterization of Saudi Patients From the Southwestern Province.

Evaluation of Possible Risk Factors for Avascular Necrosis of the Femoral head in patients with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only